Legend Biotech Corp ADR (LEGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -307,622 | -130,370 | -1,616 | N/A | N/A |
| Depreciation Amortization | 9,933 | 5,262 | 1,683 | N/A | N/A |
| Accounts receivable | -45,000 | -3,771 | 207,606 | N/A | N/A |
| Accounts payable and accrued liabilities | -4,348 | 2,011 | 3,239 | N/A | N/A |
| Other Working Capital | -21,464 | 52,483 | 318,707 | N/A | N/A |
| Other Operating Activity | 145,496 | -8,680 | -221,937 | 0 | 0 |
| Operating Cash Flow | $-223,005 | $-83,065 | $307,682 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 75,559 | N/A | N/A | N/A | N/A |
| PPE Investments | -45,746 | -38,562 | -20,938 | N/A | N/A |
| Purchase Sale Intangibles | -4,029 | -534 | -63 | N/A | N/A |
| Other Investing Activity | -53,982 | -20,090 | -81,318 | 0 | 0 |
| Investing Cash Flow | $-24,169 | $-58,652 | $-102,256 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 41,812 | 35,939 | N/A | N/A |
| Common Stock Issued | 463,549 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 155,330 | -27,146 | -33,438 | 0 | 0 |
| Financing Cash Flow | $618,879 | $14,666 | $2,501 | $N/A | $N/A |
| Exchange Rate Effect | 620 | 249 | 124 | N/A | N/A |
| Beginning Cash Position | 83,364 | 210,166 | 2,115 | N/A | N/A |
| End Cash Position | 455,689 | 83,364 | 210,166 | N/A | N/A |
| Net Cash Flow | $372,325 | $-126,802 | $208,051 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -223,005 | -83,065 | 307,682 | N/A | N/A |
| Capital Expenditure | -45,747 | -38,636 | -20,958 | N/A | N/A |
| Free Cash Flow | -268,752 | -121,701 | 286,724 | 0 | 0 |